Robert M. Califf, MD, was sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA) on February 17, 2022.
Previously, Dr. Califf served as FDA commissioner from February 2016–February 2017. Prior to rejoining the FDA, Dr. Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries, Verily Life Sciences and Google Health. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health-care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.
Dr. Califf will now oversee the federal agency tasked with finalizing and implementing over-the-counter hearing aid regulations.
Recent Posts
Celebrating Community and Giving Back in The Big Easy
The AAA Foundation had a fantastic showing at AAA 2025+HearTECH Expo in New Orleans! With incredible supporters, generous sponsors, and fun-filled events, it was a…
Contact Your Representative: Support the Medicare Audiology Legislation
The Medicare Audiology Access Improvement Act (H.R. 2757) was reintroduced in the U.S. House—and we need your help to gain critical momentum. This bipartisan bill…
Academy Fights Hearing Aid Specialists Scope Expansion in Nevada
The Academy submitted a letter to the Nevada legislature expressing strong opposition to Assembly Bill 177. The bill proposes expanding the scope of practice for…